TD Asset Management’s 89bio ETNB Stock Holding History

TD Asset Management’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-49,600	Closed	-$766K	–	1411
2023 Q3	$766K	Buy	+49,600	New	+$833K	﹤0.01%	1192

Other funds holding ETNB

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

TD Asset Management's ETNB Position: Q4 2023 in Review

TD Asset Management sold out of 89bio (ETNB) in Q4 2023, closing a stake of 49,600 shares — an estimated $766K sold.

TD Asset Management first reported a position in ETNB in Q3 2023 and held it in 1 quarter. The position peaked at $766K in Q3 2023. 153 funds tracked by Wall St. Rank hold ETNB as of Q4 2023.

TD Asset Management reported no remaining 89bio position as of Q4 2023 after selling out during the quarter.
TD Asset Management sold 49,600 89bio shares in Q4 2023, an estimated $766K.
TD Asset Management first reported a position in 89bio in Q3 2023 and held it in 1 quarter.
TD Asset Management's 89bio position peaked at $766K in Q3 2023.
153 funds tracked by Wall St. Rank held 89bio as of Q4 2023.

Based on TD Asset Management's 13F filing for Q4 2023, filed 12 Feb 2024.